H.B. Fuller Company (FUL) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Achieved strong Q2 2024 results with net revenue up 2.1% year-over-year to $917 million, driven by acquisitions and 3.3% volume growth, partially offset by lower pricing and negative currency effects.
Adjusted EBITDA rose 10% year-over-year to $157 million, with margin expanding 120 bps to 17.1%.
Adjusted EPS increased 20% to $1.12, driven by operating income growth.
Continued innovation, strategic acquisitions (notably ND Industries), and restructuring to optimize operations and expand in differentiated markets.
On track to deliver adjusted EBITDA margin above 20% in the next 3–5 years.
Financial highlights
Q2 2024 net revenue: $917.1M (+2.1% YoY); organic revenue flat as 3.3% volume growth was offset by price declines and currency headwinds.
Adjusted gross profit margin expanded 210–220 bps year-over-year to 31.1%.
Net income attributable to shareholders was $51.3M (+27% YoY); adjusted net income was $64M.
Adjusted SG&A rose 9% year-over-year, driven by acquisitions and wage inflation.
Year-to-date operating cash flow up $21M year-over-year to $129M.
Outlook and guidance
FY2024 net revenue growth expected at 2–4%, with organic revenue flat to up 2%.
Adjusted EBITDA guidance raised to $620–$640 million (7–10% growth year-over-year).
Adjusted EPS forecasted at $4.20–$4.45, up 9–15% year-over-year.
Full-year operating cash flow expected between $300–$350 million.
Q3 adjusted EBITDA projected at $165–$175 million.
Latest events from H.B. Fuller Company
- Q2 2026 saw strong revenue, margin, and EPS growth, with a major medical acquisition announced.FUL
Q2 2026 - All proposals passed, including director elections and auditor ratification, with no shareholder questions.FUL
AGM 2026 - Adjusted EBITDA and EPS rose with margin expansion despite a 6.6% organic revenue decline.FUL
Q1 2026 - Proxy covers director elections, auditor ratification, pay, strong results, and ESG focus.FUL
Proxy Filing - Votes will be cast for director elections, auditor ratification, and executive pay approval.FUL
Proxy Filing - Margin and EPS growth achieved through cost actions and acquisitions despite revenue headwinds.FUL
Q4 2025 - Adjusted EBITDA and EPS grew 5% year-over-year, with margin gains and raised full-year guidance.FUL
Q2 2025 - Q3 2024 saw 6% EBITDA and 7% EPS growth, led by strong Construction Adhesives results.FUL
Q3 2024 - FY24 revenue up 1.6%, margin at 16.6%; 2025 outlook cautious with cost and footprint actions.FUL
Q4 2024